4//SEC Filing
Ruffo Frank 4
Accession 0001209191-22-008849
CIK 0001557746other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:18 PM ET
Size
4.8 KB
Accession
0001209191-22-008849
Insider Transaction Report
Form 4
Ruffo Frank
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-02-09$12.66/sh−1,388$17,568→ 172,359 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654450
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:18 PM ET
- Size
- 4.8 KB